Actively Recruiting
Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial
Led by University of Lausanne Hospitals · Updated on 2024-08-13
24
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
Sponsors
U
University of Lausanne Hospitals
Lead Sponsor
I
International Psychoanalytical Association
Collaborating Sponsor
AI-Summary
What this Trial Is About
The first study proposed is a small (n= 10 to 12 maximum) open feasibility trial of CAVEAT which is a 16-session manualized brief psychotherapy prototcol that is designed to help mothers of infants and young children, whereby the mothers have been exposed to interpersonal violence (i.e. childhood maltreatment and family violence, intimate and non-intimate partner violence, interpersonal combat and or other forms of terrorism or political violence including physical and sexual assault) and who have developed related post-traumatic stress. The treatment uses an integration and extension of evidence-based techniques: Modified Interaction Guidance, Prolonged Exposure Therapy for PTSD, Child-Parent Psychotherapy, and Minding the Baby, in order to help mothers with post-traumatic dysregulation and difficulty in their maintaining sensitivity during challenging parent-child interactions (i.e. when mothers are confronted with child helpless states, emotion dysregulation, negative affect and child aggression). Outcome measures will initially include: maternal attributions towards her child (i.e. perception of child's personality), maternal-child behavior, and maternal-child symptoms of attachment disturbance and PTSD. This feasibility study is meant to perfect the manual and to prepare for an initial open trial with a larger clinical sample including analysis of pre- and post-intervention measures before further randomized control study can be done.
CONDITIONS
Official Title
Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biological mothers of infants and young children ages 12-54 months
- Mothers and infants have lived together most of the child's life from the time of birth
You will not qualify if you...
- Actively psychotic or substance-abusing mothers
- Mothers and/or children who are physically or mentally handicapped so as to prevent adequate participation in required research tasks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lausanne University Hospital
Lausanne, Canton of Vaud, Switzerland, 1004
Actively Recruiting
Research Team
D
Daniel S Schechter, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here